Wellvii™ and B-Secur Announce Strategic Partnership to Integrate Single-Lead ECG into BP Go, Creating the Most Compact At-Home  BP/ECG Combination Device

October 2, 2024 – Wellvii Inc., creators of the FDA-cleared blood pressure from the finger that replaces the traditional NIBP arm cuff, today announced a strategic partnership with B-Secur, a leader in advanced biosensing technology.

This collaboration brings B-Secur’s cutting-edge single-lead ECG software into Wellvii’s BP Go, revolutionizing the at-home blood pressure and heart health monitoring market.

The BP Go Rhythm BP/ECG device will offer more convenience, comfort, and portability than existing devices, making it a game-changer for ambulatory, remote patient monitoring, and home monitoring. With Bluetooth and cellular IoT connectivity, it provides seamless data sharing for enhanced patient care worldwide.

“The BP Go Rhythm puts cardiac health directly into the hands of patients with a level of comfort, portability, and connectivity that surpasses anything currently available,” said Mark Khachaturian, Wellvii CEO.

Brian Pitstick, Chief Commercial Officer at B-Secur, added, “This partnership represents a significant step forward in delivering advanced heart health solutions to a broader audience. By combining our FDA-cleared HeartKey® ECG software technology with Wellvii’s innovative BP Go, we’re enabling more accessible clinical-grade cardiac monitoring for consumers and health management professionals alike.”